Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Scaldaferri

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
European Review for Medical and Pharmacological Sciences|January 19, 2019
Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiotaF Franceschi, V Ojetti, M Candelli, et al.
Beneficial Microbes|September 5, 2020
Increased <i>Faecalibacterium</i> abundance is associated with clinical improvement in patients receiving rifaximin treatmentF R Ponziani, F Scaldaferri, M De Siena, et al.
Frontiers in Immunology|January 30, 2023
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosisC Caruso, L Laterza, C R Settanni, et al.
European Review for Medical and Pharmacological Sciences|July 17, 2014
Management of acute dyarrhea: current and future trendsF Franceschi, F Scaldaferri, M E Riccioni, et al.
Gastroenterology Research and Practice|January 28, 2017
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical GuideF Scaldaferri, M Pizzoferrato, L R Lopetuso, et al.
European Review for Medical and Pharmacological Sciences|January 21, 2014
Tricks for interpreting and making a good report on hydrogen and 13C breath testsG D'Angelo, T A Di Rienzo, F Scaldaferri, et al.
European Review for Medical and Pharmacological Sciences|October 4, 2021
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year periodF Scaldaferri, A Papa, D Napolitano, et al.
Transplantation Proceedings|April 26, 2016
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-AnalysisF Scaldaferri, S Pecere, V Petito, et al.
European Review for Medical and Pharmacological Sciences|September 7, 2020
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factorsF Scaldaferri, G Angelino, E F Romeo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 13, 2023
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care studyS Saibeni, C Bezzio, F Bossa, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
European Review for Medical and Pharmacological Sciences|January 19, 2019
Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiotaF Franceschi, V Ojetti, M Candelli, et al.
Beneficial Microbes|September 5, 2020
Increased <i>Faecalibacterium</i> abundance is associated with clinical improvement in patients receiving rifaximin treatmentF R Ponziani, F Scaldaferri, M De Siena, et al.
Frontiers in Immunology|January 30, 2023
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosisC Caruso, L Laterza, C R Settanni, et al.
European Review for Medical and Pharmacological Sciences|July 17, 2014
Management of acute dyarrhea: current and future trendsF Franceschi, F Scaldaferri, M E Riccioni, et al.
Gastroenterology Research and Practice|January 28, 2017
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical GuideF Scaldaferri, M Pizzoferrato, L R Lopetuso, et al.
European Review for Medical and Pharmacological Sciences|January 21, 2014
Tricks for interpreting and making a good report on hydrogen and 13C breath testsG D'Angelo, T A Di Rienzo, F Scaldaferri, et al.
European Review for Medical and Pharmacological Sciences|October 4, 2021
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year periodF Scaldaferri, A Papa, D Napolitano, et al.
Transplantation Proceedings|April 26, 2016
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-AnalysisF Scaldaferri, S Pecere, V Petito, et al.
European Review for Medical and Pharmacological Sciences|September 7, 2020
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factorsF Scaldaferri, G Angelino, E F Romeo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 13, 2023
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care studyS Saibeni, C Bezzio, F Bossa, et al.
Pageof 5